PHE_Purchase of RapiPREP Nucleic Acid Extraction Kit

Concepts

• medical kits
• salisbury
• uk government
• covid
• rapiprep viral lysis buffer
• extractions
• purchase of rapiprep nucleic acid extraction kit
• public health emergency of international concern
• pheic
• world health organisation

Location

United Kingdom:

Description

The UK Government must protect the health and wellbeing of UK citizens. The COVID-19 outbreak is a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organisation on 30 January 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 March 2020. PHE discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health and Social Care within the scope of the Civil Contingencies Act 2004 (CCA 2004). This urgent requirement is in response to the recent COVID -19 outbreak. The negotiated procedure without a prior publication has been used due to extreme urgency on the grounds of regulation 32(2)(c) as the purchase of RapiPREP Nucleic Acid Extraction Kit for Extractions and RapiPREP Viral Lysis Buffer for Swabs will provide additional lab capacity for Covid-19 activity.

Total Quantity or Scope

Purchase of RapiPREP Nucleic Acid Extraction Kit for Extractions and RapiPREP Viral Lysis Buffer for Swabs to provide additional lab capacity for Covid-19 activity.

Award Detail

Award Criteria

CPV Codes

• 33141620 - Medical kits

Legal Justification

The UK Government must protect the health and wellbeing of UK citizens. The COVID-19 outbreak is a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organisation on 30 January 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 March 2020. PHE discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health and Social Care within the scope of the Civil Contingencies Act 2004 (CCA 2004). This urgent requirement is in response to the recent COVID -19 outbreak. The negotiated procedure without a prior publication has been used due to extreme urgency on the grounds of regulation 32(2)(c) as the purchase of RapiPREP Nucleic Acid Extraction Kit for Extractions and RapiPREP Viral Lysis Buffer for Swabs will provide additional laboratory capacity for Covid-19 activity

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The contract with the supplier was signed on 21 December 2020; however, purchases have been made since the beginning of the pandemic from 1 April 2020 for Covid-19 activities.